Surgical aortic valve replacement should remain the standard treatment for aortic stenosis

Despite the promising results of the 'Placement of Aortic Transcatheter Valves (PARTNER) trial,' featured in the Oct. 21 issue of the New England Journal of Medicine, a cardiothoracic surgeon from Boston Medical Centre (BMC) believes that surgical aortic-valve replacement should remain the standard treatment of aortic stenosis. In the accompanying editorial, the author argues that Transcatheter aortic-valve implantation (TAVI) should be reserved for patients at inordinately high risk who are not suitable candidates for surgery and who have decreased life expectancy...

Read the whole article on

More from